SPL 2.20% 8.9¢ starpharma holdings limited

Ann: US patent issued for DEP cabazitaxel nanoparticle, page-28

  1. 2,059 Posts.
    lightbulb Created with Sketch. 302
    Well done Domesticgod for finding this interesting document.

    This shows that our scientists have been recently conducting experiments on rabbit eyes with a degree of success which has lead to their conclusion that further development would be a good idea.

    Well it's only taken 8 years to reach this point.

    This is a classic demonstration of the shareholders being kept in a void and given absolutely no indication of the activity in their laboratories. Of course we do not expect a blow by blow account but we are told there's a huge market opportunity and we're in commercial discussions in 2013 only to find out courtesy of some good diligence from Domesticgod that further development would be a smart move in 2021 after what l conclude to be recent studies.

    Any comments from the more scientifically savvy members of HC would be welcome on this study.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
8.9¢
Change
-0.002(2.20%)
Mkt cap ! $36.67M
Open High Low Value Volume
9.3¢ 9.3¢ 8.9¢ $29.39K 323.4K

Buyers (Bids)

No. Vol. Price($)
2 242435 8.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.1¢ 20000 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.